These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7420269)

  • 1. Gastrointestinal absorption of quinidine from some solutions and commercial tablets.
    Guentert TW; Upton RA; Holford NH; Bostrom A; Riegelman S
    J Pharmacokinet Biopharm; 1980 Jun; 8(3):243-55. PubMed ID: 7420269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioavaiability of four commercial quinidine sulfate tablets.
    Strum JD; Colaizzi JL; Jaffe JM; Martineau PC; Poust RI
    J Pharm Sci; 1977 Apr; 66(4):539-42. PubMed ID: 576879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of a commercial sustained-release quinidine tablet compared to oral quinidine solution.
    Sawyer WT; Pulliam CC; Mattocks A; Foster J; Hadzija BW; Rosenthal HM
    Biopharm Drug Dispos; 1982; 3(4):301-10. PubMed ID: 7159686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability characteristics of commercial quinidine polygalacturonate and sulfate tablets.
    Dahl JR; Ueda CT; Meyers DG; Wulf BG
    DICP; 1990; 24(7-8):685-8. PubMed ID: 2375136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.
    Zinny MA; Taggart WV
    Clin Ther; 1984; 7(1):22-7. PubMed ID: 6518461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of three commercial sustained-release tablets of quinidine in maintenance therapy.
    Huynh-Ngoc T; Chabot M; Sirois G
    J Pharm Sci; 1978 Oct; 67(10):1456-9. PubMed ID: 702302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative bioavailability of quinidine gluconate and quinidine sulfate in healthy volunteers.
    Covinsky JO; Russo J; Kelly KL; Cashman J; Amick EN; Mason WD
    J Clin Pharmacol; 1979; 19(5-6):261-9. PubMed ID: 469022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition kinetics of two oral forms of quinidine.
    Mahon WA; Mayersohn M; Inaba T
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):566-75. PubMed ID: 1277713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute quinidine bioavailability.
    Ueda CT; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Sep; 20(3):260-5. PubMed ID: 954347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary fat content on the bioavailability of a sustained release quinidine gluconate tablet.
    Martinez MN; Pelsor FR; Shah VP; Skelly JP; Honigberg IL; Hemingway SM; Gallo JM; Kotzan JA; Zaman R; Brown WJ
    Biopharm Drug Dispos; 1990; 11(1):17-29. PubMed ID: 2322634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption of quinidine from an enteric-coated preparation.
    Fremstad D; Nilsen OG; Amlie J; Storstein L; Olsson B; Jacobsen S
    Eur J Clin Pharmacol; 1979 Sep; 16(2):107-12. PubMed ID: 499306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies.
    Guentert TW; Holford NH; Coates PE; Upton RA; Riegelman S
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):315-30. PubMed ID: 512840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric coated quinidine compared to sustained release preparations during repeated administration.
    Bakke OM; Aanderud L; Aslaksen A
    Acta Med Scand; 1980; 207(3):183-7. PubMed ID: 7368984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of quinidine absorption with disintegration and dissolution rates.
    Strum JD; Ebersole JW; Jaffe JM; Colaizzi JL; Poust RI
    J Pharm Sci; 1978 Apr; 67(4):568-9. PubMed ID: 641776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative quinidine plasma profiles at steady state of two controlled-release products and quinidine sulfate in solution.
    Wright GJ; Melikian AP; Pitts JE; Crowe JT; Morley EM
    Biopharm Drug Dispos; 1987; 8(2):159-72. PubMed ID: 3593896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of quinidine in congestive heart failure.
    Ueda CT; Dzindzio BS
    Br J Clin Pharmacol; 1981 Jun; 11(6):571-7. PubMed ID: 7272173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of tablet hardness and food intake on the absorption of drugs.
    Otto U; Surén G
    Acta Pharm Suec; 1973 Dec; 10(6):469-76. PubMed ID: 4773114
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of food on the comparative bioavailability of a fast- and slow-release dosage form of quinidine gluconate.
    Spénard J; Sirois G; Gagnon MA
    Int J Clin Pharmacol Ther Toxicol; 1983 Jan; 21(1):1-9. PubMed ID: 6832862
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relative bioavailability of various quinidine preparations in man after a single oral dose].
    Terhaag B; Gieszinger U
    Pharmazie; 1982 Dec; 37(12):848-50. PubMed ID: 7163373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.